<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Wakefulness Promoting Medications in 2026	</title>
	<atom:link href="https://sankihealth.com/wakefulness-promoting-medications-in-2026/feed/" rel="self" type="application/rss+xml" />
	<link>https://sankihealth.com/wakefulness-promoting-medications-in-2026/</link>
	<description>Integrative Medicine and Health</description>
	<lastBuildDate>Sat, 13 Jun 2026 11:17:41 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
	<item>
		<title>
		By: Benzodiazepines in 2026: What Patients Should Know - Japanese Acupuncture		</title>
		<link>https://sankihealth.com/wakefulness-promoting-medications-in-2026/#comment-261</link>

		<dc:creator><![CDATA[Benzodiazepines in 2026: What Patients Should Know - Japanese Acupuncture]]></dc:creator>
		<pubDate>Sat, 13 Jun 2026 11:17:41 +0000</pubDate>
		<guid isPermaLink="false">https://sankihealth.com/?p=931#comment-261</guid>

					<description><![CDATA[[&#8230;] Long-term, open-ended prescribing for generalized anxiety disorder has fallen out of favor, largely because cognitive behavioral therapy and certain antidepressants produce comparable or better outcomes over time without the dependence risk. Benzodiazepines are also generally avoided as a primary treatment for insomnia beyond a few weeks, given the availability of behavioral approaches and other medications with lower dependence potential. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Long-term, open-ended prescribing for generalized anxiety disorder has fallen out of favor, largely because cognitive behavioral therapy and certain antidepressants produce comparable or better outcomes over time without the dependence risk. Benzodiazepines are also generally avoided as a primary treatment for insomnia beyond a few weeks, given the availability of behavioral approaches and other medications with lower dependence potential. [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
